This week, a remarkable scientific breakthrough was achieved with the first-ever application of a personalized in vivo gene editing treatment in a baby. Researchers developed a therapy targeting a rare mutation in the *CPS1* gene, showing significant improvement after three doses and opening new possibilities in precision medicine.
Dra Adriana Perez-Grovas Saltijeral 
Debe estar conectado para enviar un comentario.